longraredisease

Rare-disease long-read sequencing analysis for SNV, SV, CNV, STR, and methylation variants is run using the nf-core/longraredisease pipeline from a validated samplesheet and reference genome. It supports Oxford Nanopore and PacBio cohorts.

Yes, long-read variant calling supports both Oxford Nanopore and PacBio data within the same workflow. The pipeline processes these cohort datasets to detect SNV, SV, CNV, STR, and methylation calls.

Reproducible execution and provenance capture for rare-disease long-read pipeline runs are ensured through schema-constrained parameters, release-pinned execution, and documented outputs. This configuration keeps results easier to review and repeat.

Configuring Nextflow bioinformatics workflows for rare disease analysis without manual setup is handled by packaging the nf-core pipeline, schema-validated parameters, and run instructions together. This removes the effort of manual configuration.

Yes, a validated samplesheet and FASTA reference genome are required to start long-read variant analysis. Schema-validated inputs avoid invalid runs and guesswork by constraining parameters before execution.

Schema-constrained parameters for long-read rare disease workflows limit flexibility by enforcing strict input validation and release-pinned execution. This prevents invalid runs but requires inputs to strictly match the expected schema format.